Drug or technology
9 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 21, 2026 · JOURNAL ARTICLE
Expert Review of Vaccines
A comprehensive expert review synthesizing mechanistic foundations and emerging strategies for trained immunity-based vaccine adjuvants, providing a conceptual framework and translational roadmap rather than reporting original experimental or clinical data.
AUG 4, 2026 · JOURNAL ARTICLE
Virology
This is a narrative review synthesizing structure-guided protein engineering strategies and preclinical immunogenicity data, raising mechanistic questions about pre-F stabilization rather than reporting a definitive clinical or confirmatory experimental result.
JUL 28, 2026 · JOURNAL ARTICLE
Virulence
This is a narrative review synthesizing prior literature on S. suis serotype 2 virulence mechanisms; it raises questions and organizes existing knowledge rather than reporting new experimental evidence or clinical outcomes.
Narrative review of evidence suggesting route of BCG administration affects efficacy, without original trial data or quantitative synthesis.
JUL 10, 2026 · REVIEW/COMPARISON ANALYSIS
Emerging Microbes & Infections
A narrative synthesis of human epidemiological and clinical data on two related viruses to inform vaccine development strategy, without new primary data or comparative efficacy evidence.
JUL 6, 2026 · REVIEW/PERSPECTIVE
Human Vaccines & Immunotherapeutics
A translational framework review synthesizing adjuvant mechanisms and design strategies without reporting original comparative data.
JUN 27, 2026 · JOURNAL ARTICLE
Talanta
A bibliometric analysis mapping research trends and technique landscapes; describes the field rather than testing a clinical hypothesis or intervention outcome.
JUN 22, 2026 · JOURNAL ARTICLE
Virulence
Narrative review synthesizing current Lyme disease vaccine development platforms and proposing strategic directions without presenting original clinical or experimental data.